 | • レポートコード：QYR2104Z0940 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、骨肉腫診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、凍結手術、外科的治療、標的療法）、用途別市場規模（マルチスペシャリティ病院、がん研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・骨肉腫診断・治療の市場動向 ・企業の競争状況、市場シェア ・骨肉腫診断・治療の種類別市場規模（放射線療法、化学療法、凍結手術、外科的治療、標的療法） ・骨肉腫診断・治療の用途別市場規模（マルチスペシャリティ病院、がん研究センター、その他） ・骨肉腫診断・治療の北米市場規模2016-2027（アメリカ、カナダ） ・骨肉腫診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・骨肉腫診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・骨肉腫診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・骨肉腫診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ablynx、Allergan、AVEO Pharmaceuticals、Amgen、Novartis、Bayer、Pfizer、Celldex Therapeutics、Debiopharm、Eli Lilly、Roche、Galapagos、Infinity Pharmaceuticals、Medivir、Merrion Pharmaceuticals） ・結論 |
Market Analysis and Insights: Global Bone Cancer Diagnosis and Therapeutics Market
The global Bone Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bone Cancer Diagnosis and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bone Cancer Diagnosis and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bone Cancer Diagnosis and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bone Cancer Diagnosis and Therapeutics market.
Global Bone Cancer Diagnosis and Therapeutics Scope and Market Size
Bone Cancer Diagnosis and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Cancer Diagnosis and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Radiation therapies
Chemotherapy
Cryosurgery
Surgical treatment
Targeted therapy
Segment by Application
Multispecialty hospitals
Cancer research centers
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Ablynx
Allergan
AVEO Pharmaceuticals
Amgen
Novartis
Bayer
Pfizer
Celldex Therapeutics
Debiopharm
Amgen
Novartis
Galapagos
Infinity Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiation therapies
1.2.3 Chemotherapy
1.2.4 Cryosurgery
1.2.5 Surgical treatment
1.2.6 Targeted therapy
1.3 Market by Application
1.3.1 Global Bone Cancer Diagnosis and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Multispecialty hospitals
1.3.3 Cancer research centers
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bone Cancer Diagnosis and Therapeutics Market Perspective (2016-2027)
2.2 Bone Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Bone Cancer Diagnosis and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bone Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Bone Cancer Diagnosis and Therapeutics Industry Dynamic
2.3.1 Bone Cancer Diagnosis and Therapeutics Market Trends
2.3.2 Bone Cancer Diagnosis and Therapeutics Market Drivers
2.3.3 Bone Cancer Diagnosis and Therapeutics Market Challenges
2.3.4 Bone Cancer Diagnosis and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bone Cancer Diagnosis and Therapeutics Players by Revenue
3.1.1 Global Top Bone Cancer Diagnosis and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Bone Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Bone Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bone Cancer Diagnosis and Therapeutics Revenue
3.4 Global Bone Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.4.1 Global Bone Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bone Cancer Diagnosis and Therapeutics Revenue in 2020
3.5 Bone Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.6 Key Players Bone Cancer Diagnosis and Therapeutics Product Solution and Service
3.7 Date of Enter into Bone Cancer Diagnosis and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bone Cancer Diagnosis and Therapeutics Breakdown Data by Type
4.1 Global Bone Cancer Diagnosis and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027)
5 Bone Cancer Diagnosis and Therapeutics Breakdown Data by Application
5.1 Global Bone Cancer Diagnosis and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bone Cancer Diagnosis and Therapeutics Market Size (2016-2027)
6.2 North America Bone Cancer Diagnosis and Therapeutics Market Size by Type
6.2.1 North America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
6.3 North America Bone Cancer Diagnosis and Therapeutics Market Size by Application
6.3.1 North America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
6.4 North America Bone Cancer Diagnosis and Therapeutics Market Size by Country
6.4.1 North America Bone Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Bone Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bone Cancer Diagnosis and Therapeutics Market Size (2016-2027)
7.2 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Type
7.2.1 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Application
7.3.1 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Country
7.4.1 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bone Cancer Diagnosis and Therapeutics Market Size (2016-2027)
9.2 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Type
9.2.1 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Application
9.3.1 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Country
9.4.1 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ablynx
11.1.1 Ablynx Company Details
11.1.2 Ablynx Business Overview
11.1.3 Ablynx Bone Cancer Diagnosis and Therapeutics Introduction
11.1.4 Ablynx Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.1.5 Ablynx Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Bone Cancer Diagnosis and Therapeutics Introduction
11.2.4 Allergan Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 AVEO Pharmaceuticals
11.3.1 AVEO Pharmaceuticals Company Details
11.3.2 AVEO Pharmaceuticals Business Overview
11.3.3 AVEO Pharmaceuticals Bone Cancer Diagnosis and Therapeutics Introduction
11.3.4 AVEO Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.3.5 AVEO Pharmaceuticals Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Bone Cancer Diagnosis and Therapeutics Introduction
11.4.4 Amgen Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Bone Cancer Diagnosis and Therapeutics Introduction
11.5.4 Novartis Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Bone Cancer Diagnosis and Therapeutics Introduction
11.6.4 Bayer Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Bone Cancer Diagnosis and Therapeutics Introduction
11.7.4 Pfizer Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Celldex Therapeutics
11.8.1 Celldex Therapeutics Company Details
11.8.2 Celldex Therapeutics Business Overview
11.8.3 Celldex Therapeutics Bone Cancer Diagnosis and Therapeutics Introduction
11.8.4 Celldex Therapeutics Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.8.5 Celldex Therapeutics Recent Development
11.9 Debiopharm
11.9.1 Debiopharm Company Details
11.9.2 Debiopharm Business Overview
11.9.3 Debiopharm Bone Cancer Diagnosis and Therapeutics Introduction
11.9.4 Debiopharm Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.9.5 Debiopharm Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Bone Cancer Diagnosis and Therapeutics Introduction
11.10.4 Eli Lilly Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Bone Cancer Diagnosis and Therapeutics Introduction
11.11.4 Roche Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Galapagos
11.12.1 Galapagos Company Details
11.12.2 Galapagos Business Overview
11.12.3 Galapagos Bone Cancer Diagnosis and Therapeutics Introduction
11.12.4 Galapagos Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.12.5 Galapagos Recent Development
11.13 Infinity Pharmaceuticals
11.13.1 Infinity Pharmaceuticals Company Details
11.13.2 Infinity Pharmaceuticals Business Overview
11.13.3 Infinity Pharmaceuticals Bone Cancer Diagnosis and Therapeutics Introduction
11.13.4 Infinity Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.13.5 Infinity Pharmaceuticals Recent Development
11.14 Medivir
11.14.1 Medivir Company Details
11.14.2 Medivir Business Overview
11.14.3 Medivir Bone Cancer Diagnosis and Therapeutics Introduction
11.14.4 Medivir Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.14.5 Medivir Recent Development
11.15 Merrion Pharmaceuticals
11.15.1 Merrion Pharmaceuticals Company Details
11.15.2 Merrion Pharmaceuticals Business Overview
11.15.3 Merrion Pharmaceuticals Bone Cancer Diagnosis and Therapeutics Introduction
11.15.4 Merrion Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
11.15.5 Merrion Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bone Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radiation therapies
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Cryosurgery
Table 5. Key Players of Surgical treatment
Table 6. Key Players of Targeted therapy
Table 7. Global Bone Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bone Cancer Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Bone Cancer Diagnosis and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Bone Cancer Diagnosis and Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Bone Cancer Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Table 13. Bone Cancer Diagnosis and Therapeutics Market Trends
Table 14. Bone Cancer Diagnosis and Therapeutics Market Drivers
Table 15. Bone Cancer Diagnosis and Therapeutics Market Challenges
Table 16. Bone Cancer Diagnosis and Therapeutics Market Restraints
Table 17. Global Bone Cancer Diagnosis and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Bone Cancer Diagnosis and Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Bone Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer Diagnosis and Therapeutics as of 2020)
Table 20. Ranking of Global Top Bone Cancer Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Bone Cancer Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bone Cancer Diagnosis and Therapeutics Product Solution and Service
Table 24. Date of Enter into Bone Cancer Diagnosis and Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Bone Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Bone Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Bone Cancer Diagnosis and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Bone Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Bone Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Bone Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Bone Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Bone Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Bone Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Bone Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Ablynx Company Details
Table 65. Ablynx Business Overview
Table 66. Ablynx Bone Cancer Diagnosis and Therapeutics Product
Table 67. Ablynx Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Ablynx Recent Development
Table 69. Allergan Company Details
Table 70. Allergan Business Overview
Table 71. Allergan Bone Cancer Diagnosis and Therapeutics Product
Table 72. Allergan Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Allergan Recent Development
Table 74. AVEO Pharmaceuticals Company Details
Table 75. AVEO Pharmaceuticals Business Overview
Table 76. AVEO Pharmaceuticals Bone Cancer Diagnosis and Therapeutics Product
Table 77. AVEO Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 78. AVEO Pharmaceuticals Recent Development
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Bone Cancer Diagnosis and Therapeutics Product
Table 82. Amgen Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Amgen Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Bone Cancer Diagnosis and Therapeutics Product
Table 87. Novartis Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Novartis Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Bone Cancer Diagnosis and Therapeutics Product
Table 92. Bayer Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Bone Cancer Diagnosis and Therapeutics Product
Table 97. Pfizer Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Pfizer Recent Development
Table 99. Celldex Therapeutics Company Details
Table 100. Celldex Therapeutics Business Overview
Table 101. Celldex Therapeutics Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Celldex Therapeutics Recent Development
Table 103. Debiopharm Company Details
Table 104. Debiopharm Business Overview
Table 105. Debiopharm Bone Cancer Diagnosis and Therapeutics Product
Table 106. Debiopharm Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Debiopharm Recent Development
Table 108. Eli Lilly Company Details
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Bone Cancer Diagnosis and Therapeutics Product
Table 111. Eli Lilly Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Eli Lilly Recent Development
Table 113. Roche Company Details
Table 114. Roche Business Overview
Table 115. Roche Bone Cancer Diagnosis and Therapeutics Product
Table 116. Roche Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Roche Recent Development
Table 118. Galapagos Company Details
Table 119. Galapagos Business Overview
Table 120. Galapagos Bone Cancer Diagnosis and Therapeutics Product
Table 121. Galapagos Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 122. Galapagos Recent Development
Table 123. Infinity Pharmaceuticals Company Details
Table 124. Infinity Pharmaceuticals Business Overview
Table 125. Infinity Pharmaceuticals Bone Cancer Diagnosis and Therapeutics Product
Table 126. Infinity Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 127. Infinity Pharmaceuticals Recent Development
Table 128. Medivir Company Details
Table 129. Medivir Business Overview
Table 130. Medivir Bone Cancer Diagnosis and Therapeutics Product
Table 131. Medivir Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 132. Medivir Recent Development
Table 133. Merrion Pharmaceuticals Company Details
Table 134. Merrion Pharmaceuticals Business Overview
Table 135. Merrion Pharmaceuticals Bone Cancer Diagnosis and Therapeutics Product
Table 136. Merrion Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 137. Merrion Pharmaceuticals Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bone Cancer Diagnosis and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Radiation therapies Features
Figure 3. Chemotherapy Features
Figure 4. Cryosurgery Features
Figure 5. Surgical treatment Features
Figure 6. Targeted therapy Features
Figure 7. Global Bone Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Multispecialty hospitals Case Studies
Figure 9. Cancer research centers Case Studies
Figure 10. Other Case Studies
Figure 11. Bone Cancer Diagnosis and Therapeutics Report Years Considered
Figure 12. Global Bone Cancer Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Bone Cancer Diagnosis and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Bone Cancer Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Bone Cancer Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Bone Cancer Diagnosis and Therapeutics Market Share by Players in 2020
Figure 17. Global Top Bone Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer Diagnosis and Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Bone Cancer Diagnosis and Therapeutics Revenue in 2020
Figure 19. Global Bone Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Bone Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Bone Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Bone Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Bone Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Bone Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Bone Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Bone Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Bone Cancer Diagnosis and Therapeutics Market Share by Region (2016-2027)
Figure 41. China Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Bone Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Bone Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Bone Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Bone Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Ablynx Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 62. AVEO Pharmaceuticals Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 67. Celldex Therapeutics Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 68. Debiopharm Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 70. Roche Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 71. Galapagos Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 72. Infinity Pharmaceuticals Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 73. Medivir Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 74. Merrion Pharmaceuticals Revenue Growth Rate in Bone Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の骨肉腫診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bone Cancer Diagnosis and Therapeutics Market The global Bone Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の中咽頭がん診断治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market The global Oropharyngeal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accu…
- 世界の肺がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Diagnosis and Therapeutics Market The global Lung Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…